baber/WOPTO huggingface dataset:
Patent CS-262692-B2 (CS)
Title: Process for preparing new derivatives of 1h,3h-pyrrolo-/1,2-c/thiazole
Inventor: FABRE JEAN-LOUIS
IPC: A61K31/435
Filed: 1987-07-02
Abstract: A compound of the general formula I;    <IMAGE>  (I)  in which R is hydrogen or a halogen or an alkyl, alkyloxy, alkylthio, trifluoromethyl, amino, alkylamino, dialkylamino, hydroxy, cyano, carboxy, alkylsulphinyl, alkylsulphonyl, sulphamido, alkylsulphamido, dialkylsulphamido, carbamoyl, alkylcarbamoyl, dialkylcarbamoyl, phenylcarbamoyl, diphenylcarbamoyl, pyridylcarbamoyl, dipyridylcarbamoyl, benzyl, alkylcarbonyl, benzoyl, alkyloxycarbonyl, phenoxycarbonyl, alkylcarbonyloxy, benzoyloxy, alkylcarbonylamino, benzamido, phenyl, phenoxy or phenylthio group, X is oxygen or sulphur or an imino, alkylimino, phenylimino, benzylimino, sulphinyl, sulphonyl, carbonyl, carbonylmethylene, methylenecarbonyl, carbonylvinylene or vinylenecarbonyl group, or X represents a valency bond or a straight-chain alkylene group containing 1 to 4 carbon atoms and Ar is a phenyl, naphthyl, pyridyl, quinolinyl, isoquinolinyl, thienyl, benzothienyl, thieno[3,2-b]thien-2-yl or thieno[2,3-b]thien-2-yl group, it being possible for the group Ar to be unsubstituted or substituted with one or more halogen or alkyl, alkyloxy, alkylthio, trifluoromethyl, amino, alkylamino, dialkylamino, hydroxy, cyano, carboxy, alkylsulphinyl, alkylsulphonyl, sulphamido, alkylsulphamido, dialkylsulphamido, carbamoyl, alkylcarbamoyl, dialkylcarbamoyl, phenylcarbamoyl, diphenylcarbamoyl, pyridylcarbamoyl, dipyridylcarbamoyl, benzyl, alkylcarbonyl, benzoyl, alkyloxycarbonyl, phenoxycarbonyl, alkylcarbonyloxy, benzoyloxy, alkylcarbonylamino or benzamido group; each alkyl moiety containing 1 to 4 straight- or branched-chain carbon atoms; the compound being in separate enantiomeric form or mixtures thereof or a pharmaceutically acceptable salt thereof is useful in the treatment of all the pathological conditions in which PAF-acether may be directly or indirectly implicated.
Patent CS-274601-B2 (CS)
Title: Method of 1,8-naphthyridine derivative production
Inventor: MATSUMOTO JUN-ICHI
IPC: C07D213/85
Filed: 1984-07-19
Abstract: The present invention relates to a 1,8-naphthyridine derivative of the formulawherein R<sub>1</sub>, R<sub>2</sub> and R<sub>3</sub> are the same or different and each hydrogen or lower alkyl having 1 to 5 carbon atoms; and esters thereof and salts thereof and processes for preparation thereof. These compounds show excellent antibacterial activity and are useful antibacterial agents.
Patent CS-274547-B2 (CS)
Title: Carburetter for two-stroke engine with scavenged crankcase
Inventor: AKIMOV MICHAIL GRIGORJEVIC ING
IPC: F02M19/03
Filed: 1988-09-21
Abstract: The carburettor contains a case (1) with the main channel (2), whose diffuser (7) contains an atomizer (8), whose channel (9) is connected through the inlet fuel pipe (12) with the float chamber (13). The body of the atomizer (8) is arranged in the shape of stream lines and its channel (9) is arranged in the shape of a reversed L, while its first section (10) is situated parallel with the axis of the diffuser and it widens in the direction towards the fuel part (4) of the main channel (2), and its second section (11) is connected with the inlet fuel pipe (12) and the first section (10).<IMAGE>
Patent JP-H0361156-B2 (JP)
IPC: G21C5/08
Filed: 1984-01-11
Abstract: A modular lining for adapting the containment to the core of a pressurized water nuclear reactor, consisting of juxtaposed modular blocks (5) placed between the core containment (1) and the outer surface of the core (3). Arranged between the adjacent faces of the blocks (5), there are thin packing pieces (8) maintaining a certain gap between the undrilled solid blocks (5). The blocks (5) are fixed non-contiguously to the core containment (1) by screw devices (10) cooled by water circulation. The invention applies in particular to pressurized water nuclear reactors of improved efficiency and with a varying neutron spectrum.
Patent JP-2888847-B2 (JP)
IPC: G10L13/02
Filed: 1989-01-12
Granted: 1999-05-10
Abstract: PURPOSE:To allow sentences including symbols to be read aloud in a natural way of reading by providing a symbol analyzing means which detects the symbols included in KANJI (Chinese character)-KANA (Japanese syllabary) mixed sentences and forms the rhythm information of the word string, including the above-mentioned symbols according to the words before and behind the same. CONSTITUTION:The KANJI-KANA mixed sentences are inputted and voices are synthesized in accordance with the phoneme information on the reading and others obtd. by the language analysis thereof and the rhythm information on the pauses between words, accent combinations, and others. The symbol analyzing means 11 detects the symbols included in the KANJI-KANA mixed sentences and forms the rhythm information of the word string including the symbols according to the words before and behind the same. The symbol analyzing means 11 sets the symbols as ordinary ordinary nowns if the words before and behind the same are particles or auxiliary verbs. The KANJI-KANA mixed sentences are read aloud in this way according to the applications of the symbols included therein.
Patent JP-2779617-B2 (JP)
IPC: H03H17/06
Filed: 1985-01-18
Granted: 1998-07-23
Abstract: A finite impulse response sampled data filter is provided with parallel tapped delay lines (37-41; 32-36) to one of which scaled (31) input samples are applied and to the other of which non-scaled samples are applied. The scaled and non-scaled signal samples from the parallel tapped delay lines are both made available to weighting circuits (42-46) for utilization thereby in producing weighted samples which are added (47) to produce the filtered output samples.
Patent JP-2703731-B2 (JP)
IPC: G03F7/075
Filed: 1995-01-23
Granted: 1998-01-26
Abstract: A photoimageable compsn. which can be carried in an aq. medium comprises: (A) 30-80 wt.% of a latex binder polymer with a carboxylic acid functionality which gives an acid no. of 50-250; (B) 15-50 wt.% of alpha, beta-ethylenically unsatd. monomers; (C) 0.1-25 wt.% of a photoinitiator which generates free radicals; (D) 1-40 wt.% of a neutralising base and/or a polyether polyurethane associate thickener which stabilises the compsn. as an emulsion and (E) 0.1-10 wt.% of one or more polysiloxanes. Also claimed is a dry film having a polymeric support carrying the above compsn.
Patent AU-651169-B2 (AU)
Title: Improvements relating to smoking articles
Inventor: LUKE JOHN ANTHONY
IPC: A24D1/00
Filed: 1992-01-30
Granted: 1994-07-14
Abstract: This invention provides a smoking article (1) having reduced sidestream smoke in the inter-puff period. A smoking article (1) according to the invention may comprise segments of a high level of tobacco-containing material (5) interconnected by segments of low level of tobacco-containing material(6) which are capable of maintaining smoulder in the inter-puff period and re-igniting the segments of a high level of tobacco-containing material(5) in the puff period. Alternatively, a smoking article according to another aspect of the invention may comprise a lengthwise, axially extending, tobacco-containing fuse portion (46) which sustains smoulder in the inter-puff period when surrounding tobacco material (45) is substantially extinguished and which re-ignites the extinguished material on puffing of the smoking article(1). <IMAGE>
Patent AU-660013-B2 (AU)
Title: Contrast media
Inventor: ALMEN TORSTEN
IPC: C07C237/08
Filed: 1992-03-27
Granted: 1995-06-08
Abstract: PCT No. PCT/EP92/00698 Sec. 371 Date Sep. 24, 1993 Sec. 102(e) Date Nov. 24, 1993 PCT Filed Mar. 27, 1992 PCT Pub. No. WO92/17215 PCT Pub. Date Oct. 15, 1992.An imaging contrast medium comprising a physiologically tolerable multinuclear complex (as defined in claim 1) is disclosed. The multinuclear complex contains at least two, but preferably three or more contrast enhancing atoms. For X-ray or ultrasound imaging techniques heavy metal atoms are used to enhance contrast, whereas in Magnetic Resonance Imaging paramagnetic metal atoms are contrast enhancing. Molybdenum and tungsten are preferred contrast enhancing atoms. The medium may also be used therapeutically.
Patent AU-560808-B2 (AU)
Title: N-modified oxidised olefin polymers
Inventor: SMYSER GRANVILLE LEROY
IPC: C10M149/16
Filed: 1983-05-19
Granted: 1987-04-16
Abstract: An oxidized Mannich condensation product of an oxidized olefin polymer, amine and formaldehyde yielding reactant and lube oils containing these products.
Patent AU-711410-B2 (AU)
Title: Solid cosmetic composition
Inventor: MORI TAMOTSU
IPC: A61K8/34
Filed: 1995-02-14
Granted: 1999-10-14
Abstract: A solid cosmetic composition comprising 0.1 - 10 wt.% of a spherical silica having an average particle size of 3 - 16  mu m wherein said spherical silica is adsorped with moisturizing agent. A solid cosmetic composition which can suppress oil shining without affecting natural finished appearance, and can also have moisturizing effect in a non-aqueous cosmetic composition, as necessary, can be obtained.
Patent AU-716454-B2 (AU)
Title: Procedure for determining the diffusion coefficient prevailing in the fibre wall in a suspension containing primary and secondary fibre and for determining the proportion and papermaking properties of secondary fibre
Inventor: SILENIUS PETRI
IPC: G01N13/00
Filed: 1997-05-01
Granted: 2000-02-24
Abstract: The invention relates to a procedure for determining a quantity dependent on the rate of diffusion in the fibre wall for diffusion occurring through it, in which procedure a diffusible tracer is introduced into the fibres under measurement, the fibres are suspended in an aqueous phase and the tracer concentration is determined after a certain time has elapsed since the time of suspension of the fibres, and the quantity dependent on the rate of diffusion is calculated on the basis of the concentration and time. <??>In addition, the invention relates to a procedure for determining the proportion of secondary fibre in a fibre suspension containing primary fibre and secondary fibre, in which procedure virtual diffusion coefficients are determined in the fibre wall for diffusion taking place through it in at least two fibre suspensions for which the proportions of primary and secondary fibre are known and in a fibre suspension under measurement, and that the proportion of secondary fibre in the suspension under measurement is estimated by assuming that the diffusion coefficient depends mainly linearly on the proportion of primary and secondary fibre in the fibre suspension. <IMAGE>
Patent AU-692852-B2 (AU)
Title: Block and graft copolymers and methods relating thereto
Inventor: HOFFMAN ALLAN S
IPC: C08F265/10
Filed: 1995-03-03
Granted: 1998-06-18
Abstract: There is disclosed block and graft copolymers, and hydrogels thereof, which, in one embodiment, contain both a temperature-sensitive polymer component and a pH-sensitive polymer component, and the use of such copolymers for topical drug delivery to a treatment area. The block and graft copolymers may be physically mixed with one or more drugs (or with other polymers) to form a copolymer-drug mixture. These mixtures may be applied as solid particles suspended in a pharmaceutically acceptable carrier, or as a liquid which gels upon contact with the treatment area. Upon contact with the treatment area, the pH-sensitive polymer component hydrates and swells, thereby causing release of the drug from the mixture. In addition, such hydration and swelling causes the pH-sensitive polymer component to adhere to the tissue of the treatment area, thus prolonging contact time. The temperature-sensitive polymer component resists hydration and swelling of the mixture, thereby imparting a sustained and controlled release of the drug to the treatment area. In another embodiment of this invention, block and graft copolymers, and hydrogels thereof, are disclosed having broad industrial applicability.
Patent AU-777166-B2 (AU)
Title: Betaglycan as an inhibin receptor and uses thereof
Inventor: VALE WYLIE
IPC: A61K48/00
Filed: 2000-12-14
Granted: 2004-10-07
Abstract: Inhibins and activins are protein hormones that reciprocally modulate a diversity of regulatory pathways. Competitive binding experiments revealed that betaglycan, the type III TGF-beta receptor, also functions as an inhibin receptor. Betaglycan augments the binding of inhibin to the ActRII activin receptor. By augmenting inhibin binding to ActRII, betaglycan effectively sequesters ActRII away from activin and thereby reduces activin signaling. In addition, the ActRII-betaglycan complex may generate novel signals distinct from those initiated by activin signaling via ActRII and ALK4. Betaglycan is produced in discrete nuclei of the rat brain and by specific cell types within the adult rat pituitary, testis, and ovary. The presence of betaglycan within inhibin-responsive tissues and cell types, together with the ability of this protoglycan to bind inhibin and to confer inhibin sensitivity, is consistent with a role of betaglycan as an inhibin-specific receptor mediating inhibin responses within various tissues.
Patent AU-715340-B2 (AU)
Title: Disposable test strips for determination of blood analytes, and methods and compositions for making same
Inventor: MCALEER JEROME F
IPC: C12Q1/00
Filed: 1997-02-11
Granted: 2000-01-20
Abstract: An improved disposable glucose test strip for use in a test meter of the type which receives a disposable test strip and a sample of blood from a patient and performs an electrochemical analysis is made using a working formulation containing a filler, an enzyme effective to oxidize glucose, e.g., glucose oxidase, and a mediator effective to transfer electrons from the enzyme. The working formulation is printed over a conductive carbon base layer to form a working electrode. The filler, for example a silica filler, is selected to have a balance of hydrophobicity and hydrophilicity such that one drying it forms a two-dimensional network on the surface of the conductive base layer. The response of this test strip is essentially temperature independent over relevant temperature ranges and is substantially insensitive to the hematocrit of the patient.
Patent AU-579996-B2 (AU)
Title: Preparation of low density, low modulus ethylene copolymers in a fluidized bed
Inventor: KAROL FREDERICK JOHN
IPC: C08F10/02
Filed: 1984-03-28
Granted: 1988-12-22
Abstract: Ethylene copolymers having a density of less than 0.91 g/cm<3> and a 1% secant modulus of less than 140,000 kPa are continuously prepared in a fluidized bed without particle agglomeration by continuously contacting, in such fluidized bed, at a temperature of from 10 DEG C up to 80 DEG C, a gaseous mixture containing (a) ethylene and at least one higher alph olefin in a molar ratio of such higher alpha olefin to ethylene of from 0.35:1 to 8.0:1, and (b) at least 25 mol percent of a diluent gas, with a catalyst composition prepared by forming a precursor composition from a magnesium compound, titanium compound, and electron donor compound; diluting said precursor composition with an inert carrier; and activating the diluted precursor composition with an organoaluminum compound.
Patent AU-717021-B2 (AU)
Title: Apparatus for supplying printed products to processing stations
Inventor: REIST WALTER
IPC: B65H5/00
Filed: 1997-05-16
Granted: 2000-03-16
Abstract: A conveyor (10) has a self-contained main conveyor line (12), a number of feed lines (14, 14') in the form of buffer lines and a return line (16, 16'). Each feed line (14, 14') is associated to a processing station (26, 26'). The feed lines (14, 14') are connected to the main conveyor line (12) by means of controlled switches (28) so that, viewed in the conveyor direction (F), any of the clamps (20) can be delivered to any desired processing station (26). This gives the device great flexibility and decouples the processing stations from the pickup of the pressroom products at the pickup station (24).
Patent AU-689276-B2 (AU)
Title: Novel dietetic phospholipid compositions and use thereof as a dietary supplement
Inventor: PONROY YVES
IPC: A23L1/30
Filed: 1995-06-12
Granted: 1998-03-26
Abstract: PCT No. PCT/FR95/00770 Sec. 371 Date Feb. 27, 1996 Sec. 102(e) Date Feb. 27, 1996 PCT Filed Jun. 12, 1995 PCT Pub. No. WO96/00016 PCT Pub. Date Jan. 4, 1996Novel dietetic compositions providing essential fatty acids from series n-3 and n-6 and containing phospholipids rich in polyunsaturated fatty acids having a very long chain and being present in egg yolks from hens given feed enriched with essential fatty acids from series n-3 and n-6, combined or mixed with food-grade carriers or diluents. Said compositions are useful as dietary supplements for infants, toddlers and the elderly.
Patent AU-666692-B2 (AU)
Title: Novel coleopteran-active (bacillus thuringiensis) isolates and genes encoding coleopteran-active toxins
Inventor: PAYNE JEWEL M
IPC: A01N63/50
Filed: 1992-11-06
Granted: 1996-02-22
Abstract: Certain known and available strains of Bacillus thuringiensis (B.t.) have been found to have activity against coleopteran pests. Previously, these strains were not known to have any insecticidal properties. The B.t. strains can be used in various environments to control coleopteran pests, e.g., the Colorado Potato Beetle.
Patent AU-738386-B2 (AU)
Title: Lectin compositions and uses thereof
Inventor: PUSZTAI ARPAD JANOS
IPC: A23L1/305
Filed: 1997-06-20
Granted: 2001-09-20
Abstract: The invention relates to use of lactins in the manufacture of medicaments for the control of mucosal cell proliferation, for the reduction and/or treatment of damage caused by a cell-damaging agent and for the reduction and/or treatment of metabolic disorders, as well as compositions and diets comprising lectins, their use in medical and non-medical fields and the use of soya waste products, in particular the soya whey fraction, in the manufacture of the above medicaments and compositions.
Patent AU-590191-B2 (AU)
Title: Process for the pasteurization of plasma or concentrates of blood coagulation factors II, VII, IX and X
Inventor: HEIMBURGER NORBERT
IPC: A61L2/04
Filed: 1984-10-05
Granted: 1989-11-02
Abstract: 1. A process for the preparation of a virtually virus-free and hepatitis-safe product of blood coagulation factors II, VII, IX and X by heating an aqueous liquid containing these factors, if appropriate in the presence of an aminoacid and/or a saccharide or sugar-alcohol, which comprises heating the solution in the presence of calcium ions and a chelating agent and, if appropriate, antithrombin III and/or heparin.
Patent AU-688969-B2 (AU)
Title: Carbamoyl carboxylic acid amides
Inventor: WETTERICH FRANK
IPC: C07C271/22
Filed: 1995-08-19
Granted: 1998-03-19
Abstract: PCT No. PCT/EP95/03303 Sec. 371 Date Mar. 3, 1997 Sec. 102(e) Date Mar. 3, 1997 PCT Filed Aug. 19, 1995 PCT Pub. No. WO96/07638 PCT Pub. Date Mar. 14, 1996Carbamoylcarboxamides of the general formula I    <IMAGE>  (I)  and their salts (R1 is unsubstituted or substituted alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl or an unsubstituted or substituted nonaromatic carbo- or heterocycle; R2 is H or unhalogenated or halogenated alkyl or cycloalkyl; R3 is unsubstituted or substituted alkyl, cycloalkyl or phenylalkyl; R4 is H or one of the radicals R3 or R3 and R4, together with the C atom to which they are bonded, are an unsubstituted or substituted carbo- or heterocycle; R5 independently of these is one of the radicals R2; X independently of one another is hydrogen, unsubstituted or substituted alkyl and/or alkenyl; Y independently of one another and of these is one of the radicals X; p,q independently of one another are 0, 1 or 2; R6 is halogen, cyano, nitro or unsubstituted or substituted alkyl, alkoxy, alkylthio or an unsubstituted or substituted phenyl group bonded via oxygen or sulfur; r is 0, 1, 2 or 3), and compositions containing them, processes for preparation, and the use of the compounds I and the compositions are described.
Patent AU-714837-B2 (AU)
Title: In vitro models of CNS function and dysfunction
Inventor: WEISS SAMUEL
IPC: C07K14/47
Filed: 1995-09-22
Granted: 2000-01-13
Abstract: The present invention concerns a method for determining the effect of at least one biological agent on a neurological disease or disorder comprising contacting a culture of proliferated neural cells, obtained by culturing a multipotent neural stem cell in a culture medium containing at least one growth factor that induces multipotent neural stem cell proliferation to obtain a culture of proliferated neural cells, with said biological agent and determining the effects of said biological agent on said neural cell.
Patent AU-622908-B2 (AU)
Title: Process for the preparation of polymers
Inventor: DOORN JOHANNES ADRIANUS VAN
IPC: B01J31/16
Filed: 1989-06-06
Granted: 1992-04-30
Abstract: Polymers of carbon monoxide and one or more olefinically unsaturated compounds are prepared by contacting with a catalyst composition comprising a Group VIII metal and a compound of the general formula R<1>M<1>-R-M<2>R<2> wherein M<1> and M<2> are chosen from sulphur, selenium and tellurium, R<1> and R<2> represent optionally polar-substituted hydrocarbyl groups and R represents a bivalent bridging group containing at least two carbon atoms in the bridge.
Patent AU-697985-B2 (AU)
Title: Neuronal apoptosis inhibitor protein, gene sequence and mutations causative of spinal muscular atrophy
Inventor: MACKENZIE ALEX E
IPC: G01N33/50
Filed: 1995-10-17
Granted: 1998-10-22
Abstract: The gene for autosomal recessive neurodegenerative disorder Spinal Muscular Atrophy has been mapped to a region of chromosome 5. The gene encodes a protein having homology with apoptosis inhibitor proteins of viruses so that the encoded protein has been labelled as a neuronal apoptosis inhibitor protein (NAIP). A deletion in the (NAIP) domain was identified in persons with Type I, II and III Spinal Muscular Atrophy (SMA) and not in the normal non-SMA population.
Patent AU-704971-B2 (AU)
Title: Beta, beta'-dihydroxy meso-substituted chlorins, isobacteriochlorins, bacteriochlorins, and methods for making the same from beta, beta'-unsubstituted tetrapyrrolic macrocycles
Inventor: DOLPHIN DAVID
IPC: C07D487/22
Filed: 1995-10-25
Granted: 1999-05-13
Abstract: A  beta , beta '-dihydroxy meso-substituted chlorin, bacteriochlorin or isobacteriochlorin compound having the formula (I) or (II):    <IMAGE>  (I)  or   <IMAGE>  (II)  wherein M is a metal. A novel method for synthesizing the compound of formula (I) or (II) comprises the steps of: a. osmylating a  beta . beta '-unsubstituted, meso-substituted porphyrin to form an osmate ester at the  beta , beta '-position, and b. reducing the osmate ester to form the corresponding  beta , beta '-dihydroxy meso-substituted chlorin, bacteriochlorin or isobacteriochlorin of formula (I) or (II).